Suppr超能文献

新发、复发和常见突变:26例17α-羟化酶/17,20-裂解酶缺乏症中国患者的临床和分子特征

New, recurrent, and prevalent mutations: Clinical and molecular characterization of 26 Chinese patients with 17alpha-hydroxylase/17,20-lyase deficiency.

作者信息

Zhang Manna, Sun Shouyue, Liu Yanling, Zhang Huijie, Jiao Yang, Wang Weiqing, Li Xiaoying

机构信息

Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Key Laboratory of Endocrine Tumor, Shanghai Institute of Endocrinology and Metabolism, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui Jin 2nd Road, Shanghai 200025, China; Department of Endocrinology & Metabolism, Shanghai Tenth People's Hospital, Tongji University School of Medicine, 301 Middle Yanchang Road, Shanghai 200072, China.

Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Key Laboratory of Endocrine Tumor, Shanghai Institute of Endocrinology and Metabolism, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui Jin 2nd Road, Shanghai 200025, China.

出版信息

J Steroid Biochem Mol Biol. 2015 Jun;150:11-6. doi: 10.1016/j.jsbmb.2015.02.007. Epub 2015 Feb 16.

Abstract

BACKGROUND

Combined 17alpha-hydroxylase/17,20-lyase deficiency (17OHD), caused by mutations in the CYP17A1 gene, is a rare autosomal recessive form of congenital adrenal hyperplasia and characterized by hyporeninemic hypokalemic hypertension, primary amenorrhea and absence of secondary sexual characteristics.

SUBJECTS AND METHODS

Twenty six 17OHD subjects from 23 Chinese families were recruited. The CYP17A1 gene was sequenced and 17alpha-hydroxylase/17,20-lyase enzymatic activities were assessed in vitro.

RESULTS

Eight CYP17A1 mutations were identified in 23 patients. Of eight mutations, c.985_987delinsAA/p.Y329Kfs and c.1460_1469del/p.D487_F489del mutations accounted for 60.8% (28/46) and 21.7% (10/46) of the mutant alleles, respectively. The enzymatic activities for both mutations were completely abolished. We also identified three novel mutations c.971_972insG/p.K325Afx, c.1464_1466delT/p.F489Sfx and c.1386G>T/p.R462S. The enzymatic activities for c.971_972insG/p.K325Afx and c.1464_1466delT/p.F489Sfx mutations were almost completely abolished, whereas the mutation c.1386G>T/p.R462S only resulted in partial reduction of 17alpha-hydroxylase (34.6%) and 17,20 lyase activities (27.0%), which is correlated with the partial 17OHD phenotype in this patient.

CONCLUSION

The c.985_987delinsAA/p.Y329Kfs and c.1460_1469del/p.D487_F489del mutations are prevalent in Chinese 17OHD patients. The genetic defects are well correlated with the phenotypes in both complete and partial forms of 17OHD.

摘要

背景

由CYP17A1基因突变引起的17α-羟化酶/17,20-裂解酶联合缺乏症(17OHD)是一种罕见的常染色体隐性先天性肾上腺增生症,其特征为低肾素性低钾血症性高血压、原发性闭经以及缺乏第二性征。

研究对象与方法

招募了来自23个中国家庭的26名17OHD患者。对CYP17A1基因进行测序,并在体外评估17α-羟化酶/17,20-裂解酶的酶活性。

结果

在23名患者中鉴定出8种CYP17A1突变。在这8种突变中,c.985_987delinsAA/p.Y329Kfs和c.1460_1469del/p.D487_F489del突变分别占突变等位基因的60.8%(28/46)和21.7%(10/46)。这两种突变的酶活性均完全丧失。我们还鉴定出三种新突变,即c.971_972insG/p.K325Afx、c.1464_1466delT/p.F489Sfx和c.1386G>T/p.R462S。c.971_972insG/p.K325Afx和c.1464_1466delT/p.F489Sfx突变的酶活性几乎完全丧失,而c.1386G>T/p.R462S突变仅导致17α-羟化酶活性部分降低(34.6%)和17,20-裂解酶活性部分降低(27.0%),这与该患者的部分17OHD表型相关。

结论

c.985_987delinsAA/p.Y329Kfs和c.1460_14

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验